Valuation: Perrigo Company plc

Market Cap 1.87B 1.63B 1.54B 1.4B 2.62B 179B 2.63B 18.45B 7.12B 91.26B 7.03B 6.87B 294B P/E 2026 *
1,348x
P/E 2027 * 11.2x
Enterprise Value 4.78B 4.16B 3.93B 3.57B 6.69B 458B 6.72B 47.1B 18.17B 233B 17.94B 17.54B 750B EV / Sales 2026 *
1.18x
EV / Sales 2027 * 1.14x
Free-Float
99.6%
Yield 2026 *
8.58%
Yield 2027 * 8.8%
1 day+0.82%
1 week-1.17%
Current month-7.79%
1 month+4.09%
3 months+31.71%
6 months+35.81%
Current year-3.02%
1 week 13.15
Extreme 13.15
14.28
1 month 13.15
Extreme 13.15
15
Current year 9.22
Extreme 9.225
15.38
1 year 9.22
Extreme 9.225
22.65
3 years 9.22
Extreme 9.225
34.6
5 years 9.22
Extreme 9.225
50.9
10 years 9.22
Extreme 9.225
99.14
Manager TitleAgeSince
Chief Executive Officer 63 2026-06-06
Director of Finance/CFO 51 2022-05-15
Chief Operating Officer - 2025-06-22
Director TitleAgeSince
Director/Board Member 75 2014-10-31
Director/Board Member 61 2016-11-06
Director/Board Member 70 2017-02-05
Date Insider Type Main position Quantity % Market Cap. Importance
9/11/26 Exercice

Director

5,192 0.0037%
9/11/26 Exercice

Director

3,133 0.0023%
9/9/26 Exercice

Executive/Senior Manager

18,186 0.0131%
Change 5-day change 1-year change 3-year change Capi.($)
+1.04%-1.17%-36.86%-60.19% 1.87B
+0.06%+3.50%+51.35%+102.13% 1,027B
+0.56%+2.31%+56.01%+67.24% 651B
+0.19%+2.79%+19.05%+71.68% 467B
-1.22%+3.66%+36.44%+38.32% 350B
-0.79%+2.73%+19.03%+25.08% 268B
+0.58%+6.76%+11.13%+16.52% 257B
+1.55%+2.15%+39.75%+46.48% 205B
+0.79%+1.84%-28.27%-56.71% 190B
-0.07%+5.00%+32.81%+99.55% 187B
Average +0.24%+2.16%+20.05%+35.01% 360.4B
Weighted average by Cap. +0.18%+2.62%+35.43%+62.10%

Financials

2026 *2027 *
Net sales 4.06B 3.54B 3.34B 3.04B 5.69B 390B 5.71B 40.04B 15.45B 198B 15.25B 14.91B 637B 4.09B 3.57B 3.37B 3.06B 5.73B 392B 5.75B 40.33B 15.56B 199B 15.36B 15.02B 642B
Net income -224M -195M -185M -168M -314M -21.5B -315M -2.21B -853M -10.93B -842M -823M -35.18B -56.95M -49.66M -46.89M -42.58M -79.78M -5.46B -80.11M -562M -217M -2.78B -214M -209M -8.94B
Net Debt 2.9B 2.53B 2.39B 2.17B 4.07B 279B 4.09B 28.65B 11.05B 142B 10.91B 10.67B 456B 2.78B 2.43B 2.29B 2.08B 3.9B 267B 3.92B 27.46B 10.59B 136B 10.46B 10.22B 437B
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change Volume
26-09-18 US$13.53 +0.37% 1,558,664
26-09-17 US$13.48 -0.44% 2,247,845
26-09-16 US$13.54 -0.15% 2,105,783
26-09-15 US$13.56 -0.66% 2,281,530
26-09-14 US$13.65 -0.07% 1,925,222
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
13.48USD
Average target price
16.50USD
Spread / Average Target
+22.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PRGO Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!